Does Your Mask/Respirator Filter Live Viruses?
23 mars 2021 03h00 HE
|
i3 BioMedical Inc.
MIRABEL, Quebec, Canada, March 23, 2021 (GLOBE NEWSWIRE) -- i3 Biomedical inc., a medical device corporation, releases today the comparative results of Live viruses Filtration performances of...
Vystar appoints Dr. Byron Novosad to Board of Directors
23 févr. 2021 08h30 HE
|
Vystar Corp.
Worcester, MA, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) has named Byron Novosad, DDS, to the Vystar Board of Directors, effective immediately. He fills the seat vacated by...
Vystar Issues Corporate Update on Strategic Initiatives and the Impact of COVID-19 on Brands
01 févr. 2021 08h30 HE
|
Vystar Corp.
Worcester, MA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST), parent company of RxAir® UV light air purification products, Rotmans Furniture and Floor Covering, and Vytex®...
AB Science annonce qu'une nouvelle publication indépendante confirme que le masitinib a une activité anti-virale contre le virus SARS-CoV-2 in vitro et est un candidat prometteur pour le traitement du Covid-19
25 janv. 2021 02h27 HE
|
AB Science
UNE NOUVELLE PUBLICATION INDÉPENDANTE CONFIRME QUE LE MASITINIB A UNE ACTIVITÉ ANTI-VIRALE CONTRE LE VIRUS SARS-COV-2 IN VITRO ET EST UN CANDIDAT PROMETTEUR POUR LE TRAITEMENT DU COVID-19 Paris, le...
AB Science announces that a new independent publication confirms that masitinib has anti-vital activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating Covid-19
25 janv. 2021 02h27 HE
|
AB Science
NEW INDEPENDENT PUBLICATION CONFIRMS THAT MASITINIB HAS ANTI-VIRAL ACTIVITY AGAINST THE SARS-COV-2 VIRUS IN VITRO AND IS A PROMISING CANDIDATE FOR TREATING COVID-19 Paris, 25 January 2021, 8.30am CET...
Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein
19 janv. 2021 17h06 HE
|
Sorrento Therapeutics, Inc.
SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced that it will be presenting preliminary results from an ongoing SARS-CoV-2 mutation...
UK Doctor Develops ‘MAYA’ (Medical Advice You Access) to Encourage People to Evaluate Their Symptoms and Take Charge of Their Health
04 janv. 2021 09h00 HE
|
AuthorHouse
LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- The global outbreak of COVID-19 has sparked a lot of healthcare discussions as many people have avoided seeking medical care to ease the strain on...
THC Therapeutics, Inc. Independently Tested, Patented Sanitizing Cannabis Dryer More Relevant Than Ever
22 déc. 2020 07h20 HE
|
THC Therapeutics Inc
The dHydronator’s SanitiZen® technology has been proven to reduce the microbial load level of cannabis from failing laboratory testing and brings the contaminants down to passing levels. THC...
La BEI soutient AB Science dans son programme de développement Covid-19
30 nov. 2020 00h56 HE
|
AB Science
Paris, 30 novembre 2020, 7 heures La BEI soutient AB Science dans son programme de développement Covid-19 Signature d’un contrat de financement de 15,0 millions d’euros pour soutenir le programme...
EIB supports AB Science in its COVID-19 development programme
30 nov. 2020 00h56 HE
|
AB Science
Paris, 30 November 2020, 7am EIB supports AB Science in its COVID-19 development programme Financing deal worth €15.0 million signed to support clinical development programme for masitinibMasitinib...